What roles do academic institutions or TTOs play as shareholders in spinoffs?

What roles do academic institutions or TTOs play as shareholders in spinoffs?

When spinning out a company, one strategy applied by the university or TTO is to often take an equity position in the start-up.
When this happens, how do the university or TTO play their role as a shareholder? Do they keep a close eye on the development of the company and continue to offer active support or do they act more as a sleeping partner? How is the risk measured and what is the exit short-term/long-term strategy chosen by those unusual shareholders?

Pascale Augé

Chairman of the Executive Management Board
France
Inserm Transfert

Grégoire Franoux

Global Head of Business Development and Licensing
Belgium
Oxurion (former Thrombogenics)

Caroline Barelle

CEO
United Kingdom
Elasmogen

Adrian Ibrahim

Head of Business Development and Technology Transfer
United Kingdom
Wellcome Sanger Institute
  • No products in the cart.